Switching to weekly semaglutide may be beneficial when other GLP-1 RAs are unable to achieve sufficient weight reduction, given that further management of obesity is recommended to achieve better cardiovascular and renal outcomes (14). The gene discussed is GCG; the disease is Obesity.